{"id":"W4396603568","doi":"10.1093/ced/llae152","title":"Cedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trial","year":2024,"lang":"en","type":"article","venue":"Clinical and Experimental Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Psoriasis; Placebo; Adverse effect; Clinical endpoint; Internal medicine; Interleukin 17; Randomized controlled trial; Gastroenterology; Dermatology; Cytokine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001211222,0.0004132901,0.002361555,0.0001741445,0.0001725126,0.00003224669,0.0001849631,0.0007498803,0.0004105305],"category_scores_gemma":[0.0002955673,0.0002620074,0.0006208189,0.0001464786,0.001351754,0.0001258611,0.0001472237,0.0005377971,0.0002640387],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001937069,"about_ca_system_score_gemma":0.0001453385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003425875,"about_ca_topic_score_gemma":0.00002546603,"domain_scores_codex":[0.9947729,0.001853563,0.001912841,0.0008842073,0.00005867909,0.0005178744],"domain_scores_gemma":[0.9964374,0.002956658,0.000186482,0.0002820334,0.00002529872,0.0001121413],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9733345,0.00363453,0.0005560921,0.00002703914,0.001281729,0.0005871112,0.0007399089,1.598328e-7,0.0001851275,0.001320849,0.001427931,0.01690501],"study_design_scores_gemma":[0.9850585,0.004492027,0.00004846003,0.0001716304,0.0004317933,0.0005955354,0.0005267434,0.0001076685,0.002513657,0.0001357464,0.005595194,0.0003230473],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9601191,0.03108431,0.0000202046,0.0006843985,0.004800445,0.002127641,0.0000239109,0.0001493658,0.0009906065],"genre_scores_gemma":[0.9962516,0.001388974,0.0001031879,0.0002985151,0.0002894945,0.0009171055,0.0001086889,0.00002980066,0.0006126299],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03613248,"threshold_uncertainty_score":0.9999832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02979389415664884,"score_gpt":0.3533725789174983,"score_spread":0.3235786847608494,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}